Atherectomy of the femoropopliteal artery: A systematic review and meta-analysis of randomized controlled trials

Journal of Cardiovascular Surgery

Volumn 55, Issue 5, 2014, Pages 655-665

  Diamantopoulos, A ^a   Katsanos, K ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Angioplasty; Atherectomy; Meta analysis; Stents

Indexed keywords

ARTIFICIAL EMBOLISM; ATHERECTOMY; ATHERECTOMY DEVICE; BAIL OUT STENTING; CAROTID ARTERY STENTING; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CRITICAL LIMB ISCHEMIA; EMBASE; FEMOROPOPLITEAL ARTERY OCCLUSIVE DISEASE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; LIMB AMPUTATION; MEDLINE; META ANALYSIS; MORTALITY RATE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SCOPUS; SENSITIVITY ANALYSIS; SUPERFICIAL FEMORAL ARTERY; SYSTEMATIC REVIEW; TREATMENT DURATION; VASCULAR PATENCY; AMPUTATION; CHI SQUARE DISTRIBUTION; FEMORAL ARTERY; LIMB SALVAGE; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; RISK; STENT; TIME; TREATMENT OUTCOME;

AMPUTATION; ANGIOPLASTY, BALLOON; ATHERECTOMY; CHI-SQUARE DISTRIBUTION; EMBOLIZATION, THERAPEUTIC; FEMORAL ARTERY; HUMANS; LIMB SALVAGE; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84925231815     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Kasapis C, Gurm HS. Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Current Cardiology Reviews 2009;5:296-311
2. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vase Surg 2000;31(1 Pt 2):S1-S296.
3. Katsanos K, Tepe G, Tsetis D, Fanelli F. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Intervent Radiol 2014;37:592-603.
4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vase Endovasc Surg 2007;33(Suppl 1):Sl-75.
5. Pastromas G, Katsanos K, Krokidis M, Karnabatidis D, Spiliopoulos S. Emerging stent and balloon technologies in the fem-oropopliteal arteries. ScientificWorldJournal 2014;2014:695402.
6. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK et al. ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Vase Surg 2011;54:e32-58.
7. Quevedo HC, Arain SA, Ali G, Abi Rafeh N. A critical view of the peripheral atherectomy data in the treatment of infrainguinal arterial disease. J Invasive Cardiol 2014;26:22-9.
8. Ambler GK, Radwan R, Hayes PD, Twine CP. Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev 2014;3:CD006680.
9. Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices [IPG380] [database on the Internet]. National Institute for Health and Clinical Excellence 2011.
10. Schwarzwalder U, Zeller T. Debulking procedures: potential device specific indications. Tech Vase Interv Radiol 2010; 13:43-53.
11. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
12. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
13. Sacks D, Marinelli DL, Martin LG, Spies JB. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. JVIR 2003;14(9 Pt 2):S395-404.
14. Brodmann M, Rief P, Froehlich H, Dorr A, Gary T, Eller P et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovasc Intervent Radiol 2013;36:69-74.
15. Gandini R, Del Giudice C, Merolla S, Morosetti D, Pampana E, Simonetti G. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther 2013;20:805-14.
16. Shammas N\V, Coiner D, Shammas GA, Dippel EJ, Christensen L, Jerin M. Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. JVIR 2011;22:1223-8.
17. Dattilo R. 12-month results of compliance 360: A prospective, multicenter, randomized trial comparing orbital atherectomy to balloon angioplasty for calcified femoropopliteal lesions. JACC 2012;59(13).
18. Nakamura S, Conroy RM, Gordon IL, Deutsch LS, Maheswaran B, Antone CS et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. JCU 1995;23:461-71.
19. Vroegindeweij D, Tielbeek AV, Buth J, Schol FP, Hop WC, Landman GH. Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. J Vase Surg 1995;21:255-68; discussion 68-9.
20. Franzone A, Ferrone M, Carotenuto G, Carbone A, Scudiero L, Serino F et al. The role of atherectomy in the treatment of lower extremity peripheral artery disease. BMC Surgery 2012;12(Suppl 1):S13.